ACTRN12605000183684
Completed
Phase 3
Detection of relapse risk and improvement of health risk behaviours in people with depression: Randomised controlled trial of correspondence-based assistance to general practitioners.
Professor David J. Kavanagh0 sites120 target enrollmentStarted: August 19, 2005Last updated:
Overview
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Professor David J. Kavanagh
- Enrollment
- 120
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to ot stated (—)
- Sex
- All
Inclusion Criteria
- •History of Major Depressive Episode but not currently meeting DSM\-IV criteria for an episode.\- sufficient oral and written English to be able to participate without translation.
Exclusion Criteria
- •History of, or current, psychotic disorder\- current dependence on any psychoactive substance (excluding nicotine and caffeine)\- in other concurrent treatment for depression (other than maintenance antidepressant medication).\- enrolled at same address as someone already involved in the study.
Investigators
Similar Trials
Not yet recruiting
Phase 3
Does Escitalopram helps in early recovery and prevent relapse in cases of idiopathic central serous retinopathy which causes blister like elevation at the centre of retina causing loss of visioHealth Condition 1: null- Idiopathic Central serous retinopathyCTRI/2011/11/002148DrGNageswar Rao110
Recruiting
Not Applicable
Testing a well-being group program to prevent relapse for individuals with mood disordersbipolar disorderdepressionACTRN12618001151224Quincy Wong15
Completed
Not Applicable
Staying Well After Depression: a randomised trialRecurrent depressionMental and Behavioural DisordersDepressive episodeISRCTN97185214niversity of Oxford (UK)300
Recruiting
Phase 2
Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M StratificationMyelodysplastic Syndromes, AdultNCT06612944Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine40
Completed
Not Applicable
Early signs monitoring to prevent relapse and promote wellbeing, engagement and recoverySchizophreniaMental and Behavioural DisordersISRCTN99559262HS Greater Glasgow & Clyde149